Oxford Nanopore Technologies
Howard has 21 years’ experience in IVD industry, including roles in product development, technology transfer and manufacturing technical support in large Corporate and start up environments. Leadership roles in establishing Design Control processes in foundation of Abbott Diabetes Care under the Consent Decree and in the first IVD CE Approval. Strong background in Design Control and Regulatory requirements.
This person is not in any offices
Oxford Nanopore Technologies
9 followers
Our goal is to enable the analysis of any living thing, by any person, in any environment. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION.